title: Estrogen receptor ligands modulate its interaction with DNA.
abstract: The estrogen receptor (ER) belongs to a superfamily of ligand-inducible transcription factors. Functions of these proteins (dimerization, DNA binding, and interaction with other transcription factors) are modulated by binding of their corresponding ligands. It is, however, controversial whether various ER ligands affect the receptor's ability to bind its specific DNA element (ERE). By using real time interaction analysis we have investigated the kinetics of human (h)ER binding to DNA in the absence and presence of 17beta-estradiol, 17alpha-ethynyl estradiol, analogs of tamoxifen, raloxifene, and ICI-182,780. We show that ligand binding dramatically influences the kinetics of hER interaction with specific DNA. We have found that binding of estradiol induces the rapid formation of a relatively unstable ER.ERE complex, and binding of ICI-182,780 leads to slow formation (ka is approximately 10 times lower) of a stable receptor-DNA complex (kd is almost 2 orders of magnitude lower). Therefore, binding of estradiol accelerates the frequency of receptor-DNA complex formation more than 50-fold, compared with unliganded ER, and more than 1000-fold compared with ER liganded with ICI-182,780. We hypothesize that a correlation exists between the rate of gene transcription and the frequency of receptor-DNA complex formation. We further show that a good correlation exists between the kinetics of hER-ERE interaction induced by a ligand and its biological effect.
authors.affiliation: Women's Health Research Institute, Wyeth-Ayerst Research, Radnor, Pennsylvania 19087, USA.
authors.forename: B J
authors.initials: BJ
authors.lastname: Cheskis
authors.forename: S
authors.initials: S
authors.lastname: Karathanasis
authors.forename: C R
authors.initials: CR
authors.lastname: Lyttle
mesh_terms: D004268:DNA-Binding Proteins / Q000378:metabolism*; D004958:Estradiol / Q000031:analogs & derivatives / Q000494:pharmacology; D004965:Estrogen Antagonists / Q000494:pharmacology; D004997:Ethinyl Estradiol / Q000494:pharmacology; D000077267:Fulvestrant; D006801:Humans; D008024:Ligands; D010880:Piperidines / Q000494:pharmacology; D011485:Protein Binding / Q000187:drug effects; D020849:Raloxifene Hydrochloride; D011960:Receptors, Estrogen / Q000378:metabolism*; D012045:Regulatory Sequences, Nucleic Acid; D013629:Tamoxifen / Q000031:analogs & derivatives; D014157:Transcription Factors / Q000378:metabolism*
chemical_list: D004268:DNA-Binding Proteins; D004965:Estrogen Antagonists; D008024:Ligands; D010880:Piperidines; D011960:Receptors, Estrogen; D014157:Transcription Factors; D013629:Tamoxifen; D000077267:Fulvestrant; D004997:Ethinyl Estradiol; D020849:Raloxifene Hydrochloride; D004958:Estradiol